Latest California Healthline Stories
“Health Minute” brings original health care and health policy reporting from the KHN newsroom to the airwaves each week.
Congress’ $1.7 trillion omnibus spending package included a two-year extension of pandemic-era funding that helped telehealth services grow nationwide. But that cash bridge, embraced by those delivering services to patients in rural areas, doesn’t provide much certainty for the future of remote medicine.
Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.
In a surprise decision, U.S. officials yield to insurance industry demands — at least for now.
A new graphic novel by Kathleen Founds follows an angst-ridden bear on his quest for mental health treatment. Founds drew on her own experience with bipolar disorder.
Just outside St. Louis, a cemetery for children sits on a hill. A wooden, weather-worn sign welcomes mourners to “Baby Land.” The gravediggers who made the special spot work quietly in the shadows.
A baby spent more than a month in a Chicago NICU. A big bill revealed she was treated by out-of-network doctors from the children’s hospital next door. Her parents were charged despite a state law protecting patients from such out-of-network billing — and sent to collections when they didn’t pay up.
In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.
A single booster seems to prevent death and hospitalization in most people, but protection from the current vaccines wanes within months. FDA experts say they need to know more from the Centers for Disease Control and Prevention to decide the best long-term strategy.
KHN has released never-before-seen details of federal audits as the government weighs action against dozens of Medicare Advantage plans.